Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.
The pathological consequences of exposure to the vaccine strain Brucella abortus S19 were evaluated in 30 employees from vaccine-manufacturing plants. Active brucellosis was diagnosed in 21 subjects, of whom only five recalled an accidental exposure. Clinical manifestations were mild, and only one patient presented a complication. After antimicrobial therapy, initially symptomatic patients either experienced clinical remission or had mild persistent symptoms. This is the first study reporting infection by B. abortus S19 among workers from vaccine-manufacturing plants, which in many cases was acquired from unnoticed exposures. Measures to improve the safety of B. abortus S19 handling should be implemented.
Wallach
J C
JC
Hospital F. J. Muñiz, Buenos Aires.
Ferrero
M C
MC
Victoria Delpino
M
M
Fossati
C A
CA
Baldi
P C
PC
D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D001118:Argentina / Q000453:epidemiology; D002004:Brucella Vaccine; D002003:Brucella abortus / Q000276:immunology* / Q000302:isolation & purification; D002006:Brucellosis / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D004345:Drug Industry / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D017056:Medical Laboratory Personnel; D008875:Middle Aged; D016273:Occupational Exposure
D000907:Antibodies, Bacterial; D002004:Brucella Vaccine